<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Analysis of serum unconjugated and conjugated <z:chebi fb="0" ids="16990">bilirubin</z:chebi> fractions by routine <z:chebi fb="1" ids="30105">diazo</z:chebi> procedures does not allow a definite diagnosis of <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>By the alkaline methanolysis procedure of Blanckaert followed by thin-layer chromatography we were able to discriminate <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> even in the presence of <z:mpath ids='MPATH_458'>normal</z:mpath> serum <z:chebi fb="0" ids="16990">bilirubin</z:chebi> concentrations from healthy subjects, patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> persistant <z:hpo ids='HP_0012115'>hepatitis</z:hpo> and patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0010163'>hemolysis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The relative proportion of unconjugated <z:chebi fb="0" ids="16990">bilirubin</z:chebi> in serum was 95 +/- 2% in patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> (n = 28), 84 +/- 5% in healthy subjects (n = 29), 75 +/- 6% in patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> persistant <z:hpo ids='HP_0012115'>hepatitis</z:hpo> (n = 7) and 85 +/- 3% in patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0010163'>hemolysis</z:mp> (n = 9) </plain></SENT>
<SENT sid="3" pm="."><plain>The difference between <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> and the control groups with <z:mpath ids='MPATH_458'>normal</z:mpath> or elevated serum <z:chebi fb="0" ids="16990">bilirubin</z:chebi> was highly significant (p less than 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>In <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e>, unconjugated <z:chebi fb="0" ids="16990">bilirubin</z:chebi> ranged between 90 and 99%, in healthy subjects between 72 and 90%, in patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> persistant <z:hpo ids='HP_0012115'>hepatitis</z:hpo> between 68 and 85% and in patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0010163'>hemolysis</z:mp> between 81 and 89% of total </plain></SENT>
<SENT sid="5" pm="."><plain>An overlap was only seen in one patient with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> and in 2 healthy subjects at the 90% level </plain></SENT>
<SENT sid="6" pm="."><plain>We conclude that in most patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> provocation tests are no longer necessary </plain></SENT>
</text></document>